David R. Helton
Publications by Year
Research Areas
Neuroscience and Neuropharmacology Research, Receptor Mechanisms and Signaling, Neurotransmitter Receptor Influence on Behavior, Nicotinic Acetylcholine Receptors Study, Pain Mechanisms and Treatments
Most-Cited Works
- → Design, Synthesis, and Pharmacological Characterization of (+)-2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic Acid (LY354740): A Potent, Selective, and Orally Active Group 2 Metabotropic Glutamate Receptor Agonist Possessing Anticonvulsant and Anxiolytic Properties(1997)392 cited
- → Anxiolytic and Side-Effect Profile of LY354740: A Potent, Highly Selective, Orally Active Agonist for Group II Metabotropic Glutamate Receptors(1998)282 cited
- → LY354740: a metabotropic glutamate receptor agonist which ameliorates symptoms of nicotine withdrawal in rats(1997)103 cited
- → 2-Substituted (2SR)-2-Amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as Potent and Selective Antagonists of Group II Metabotropic Glutamate Receptors. 2. Effects of Aromatic Substitution, Pharmacological Characterization, and Bioavailability(1998)100 cited
- → Nicotine withdrawal: a behavioral assessment using schedule controlled responding, locomotor activity, and sensorimotor reactivity(1993)82 cited
- → LY303870, a Centrally Active Neurokinin-1 Antagonist with a Long Duration of Action(1997)58 cited
- → Intracerebral 1S,3R-1-aminocyclopentane-1,3-dicarboxylic acid (1S,3R-ACPD) produces limbic seizures that are not blocked by ionotropic glutamate receptor antagonists(1993)51 cited
- → Serotonin-1A antagonists attenuate the effects of nicotine withdrawal on the auditory startle response(1997)45 cited
- → The CCK-B antagonist LY288513 blocks effects of diazepam withdrawal on auditory startle(1993)32 cited
- → The proconvulsive activity of quinolone antibiotics in an animal model(1991)31 cited